Matches in Wikidata for { <http://www.wikidata.org/entity/Q64836258> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q64836258 description "clinical trial" @default.
- Q64836258 description "ensayu clínicu" @default.
- Q64836258 description "klinisch onderzoek" @default.
- Q64836258 description "клінічне випробування" @default.
- Q64836258 name "A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)" @default.
- Q64836258 name "A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica" @default.
- Q64836258 type Item @default.
- Q64836258 label "A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)" @default.
- Q64836258 label "A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica" @default.
- Q64836258 prefLabel "A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)" @default.
- Q64836258 prefLabel "A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica" @default.
- Q64836258 P1050 Q64836258-30EF596F-E627-4A7D-8646-212F20E3E2AC @default.
- Q64836258 P1132 Q64836258-5D9BFE8B-0AF5-4FD1-8A5F-CBD6188613FB @default.
- Q64836258 P1476 Q64836258-AE732F70-EEE7-48F5-896D-02F99397DD81 @default.
- Q64836258 P17 Q64836258-380F69FC-72A0-4EAA-9440-874D32CE72BC @default.
- Q64836258 P2899 Q64836258-DF584E22-2C82-4DC9-90DE-9944DB7B7522 @default.
- Q64836258 P3098 Q64836258-9D6F0022-D263-433A-A760-9835E8904889 @default.
- Q64836258 P31 Q64836258-50D851BB-8925-4291-A8F9-A06394C54AAB @default.
- Q64836258 P4844 Q64836258-D171358F-9BED-4AAE-BD7C-F41F58F67F0A @default.
- Q64836258 P580 Q64836258-1BABEC6B-F287-48F8-A598-4922AE2525BF @default.
- Q64836258 P582 Q64836258-5752FAB2-98CF-4DE2-99ED-D0223B0115DE @default.
- Q64836258 P6099 Q64836258-822B7F15-6797-48D7-B68E-79B0DAEF81EF @default.
- Q64836258 P8363 Q64836258-F14FF3AD-BD7C-4C58-90EB-9E4DA57C5D43 @default.
- Q64836258 P1050 Q1752891 @default.
- Q64836258 P1132 "+32" @default.
- Q64836258 P1476 "A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)" @default.
- Q64836258 P17 Q40 @default.
- Q64836258 P2899 "+18" @default.
- Q64836258 P3098 "NCT03263715" @default.
- Q64836258 P31 Q30612 @default.
- Q64836258 P4844 Q17149282 @default.
- Q64836258 P580 "2017-11-24T00:00:00Z" @default.
- Q64836258 P582 "2019-09-01T00:00:00Z" @default.
- Q64836258 P6099 Q42824827 @default.
- Q64836258 P8363 Q78089383 @default.